PDE4A and Alzheimer disease: This leads to decreased cAMP levels, which in turn activates the nuclear factor (NF)-kB pathway and heightens the production of pro-inflammatory cytokines such as interleukin (IL)-4 and IL-13, as well as of prostaglandin E2, suggesting that inhibition of PDE4 may decrease the inflammatory processes associated with AD [80].